Welcome to our dedicated page for Jupiter Wellness SEC filings (Ticker: SHOTW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Jupiter Wellness Inc (SHOTW) sits at the intersection of cannabinoid science and consumer wellness, which means even a single 8-K about a clinical trial result or financing round can move the stock dramatically. If you’re scanning hundreds of pages to confirm FDA feedback on a Canidermrx study or to see how Canisun sales trends migrate through segments, you’re in the right place.
Our platform assembles every filing the moment it hits EDGAR and layers on AI-powered summaries that translate technical language into plain English. Whether you’re hunting for the Jupiter Wellness quarterly earnings report 10-Q filing, need a Jupiter Wellness annual report 10-K simplified, or want Jupiter Wellness 8-K material events explained, the key points appear upfront—cash burn, R&D commitments, and regulatory milestones included.
Dig deeper with real-time alerts on Jupiter Wellness insider trading Form 4 transactions. See patterns through our “Jupiter Wellness Form 4 insider transactions real-time” feed, monitor dilution risk from S-1s, or compare option grants via the latest Jupiter Wellness proxy statement executive compensation. Need quick context? Select “understanding Jupiter Wellness SEC documents with AI” for an instant walkthrough and concise Jupiter Wellness earnings report filing analysis. From financing covenants to Jupiter Wellness executive stock transactions Form 4, every disclosure is cataloged, summarized, and linked so you can make decisions swiftly, not sift through jargon.
Safety Shot (Nasdaq: SHOTW) filed an 8-K reporting the closing of its acquisition of Yerbaé Brands on 27 Jun 2025.
Yerbaé holders received 0.2918 Safety Shot shares for each Yerbaé share, resulting in the issuance of 19.88 million new shares and bringing total shares outstanding to 108.3 million; legacy holders now own 81.6% and Yerbaé holders 18.4%.
Assumed securities include:
- $3.8 million 6% convertible debentures (convertible at $4.80; holders may demand 105% redemption within 90 days)
- 1.83 million replacement options and 2.12 million warrants adjusted by the exchange ratio
The board expanded from six to seven directors and appointed Todd G.